Cardiovascular sequalae in uncomplicated COVID-19 survivors

Autor: Teresa Tong, Anthony Raymond Tam, Wing-Hon Lai, Polly Pang, Chu-Pak Lau, Ivan Hung, Ian C. K. Wong, Frankie C.C. Tam, Esther W. Chan, Jeffrey Chun-Yin Lee, Yee-Man Lau, Deborah Ho, Chung-Wah Siu, Hung-Fat Tse, Yat-Yin Lam, Mi Zhou, Chun-Ka Wong, Milky Oi Yan Tang, Ka-Chun Un, Ming-Yen Ng, YM Lau
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Male
Viral Diseases
Sinus bradycardia
030204 cardiovascular system & hematology
Biochemistry
Diagnostic Radiology
Electrocardiography
Ventricular Dysfunction
Left

0302 clinical medicine
Medical Conditions
Heart Rate
Atrial Fibrillation
Ultrasound Imaging
Natriuretic Peptide
Brain

Medicine and Health Sciences
030212 general & internal medicine
Prospective Studies
Survivors
Multidisciplinary
biology
medicine.diagnostic_test
Radiology and Imaging
Atrial fibrillation
Middle Aged
Troponin
Myocarditis
Infectious Diseases
Bioassays and Physiological Analysis
Echocardiography
Cardiology
cardiovascular system
Medicine
Female
medicine.symptom
Arrhythmia
Research Article
Bradycardia
Adult
medicine.medical_specialty
Heart Diseases
Imaging Techniques
Science
Research and Analysis Methods
03 medical and health sciences
Cardiac magnetic resonance imaging
Diagnostic Medicine
Intensive care
Internal medicine
medicine
Humans
cardiovascular diseases
Aged
business.industry
SARS-CoV-2
Electrophysiological Techniques
Biology and Life Sciences
Proteins
COVID-19
Covid 19
Arrhythmias
Cardiac

medicine.disease
Survival Analysis
Peptide Fragments
Cytoskeletal Proteins
biology.protein
Cardiac Electrophysiology
business
Biomarkers
Zdroj: PLoS ONE, Vol 16, Iss 2, p e0246732 (2021)
PLoS ONE
ISSN: 1932-6203
Popis: BackgroundA high proportion of COVID-19 patients were reported to have cardiac involvements. Data pertaining to cardiac sequalae is of urgent importance to define subsequent cardiac surveillance.MethodsWe performed a systematic cardiac screening for 97 consecutive COVID-19 survivors including electrocardiogram (ECG), echocardiography, serum troponin and NT-proBNP assay 1–4 weeks after hospital discharge. Treadmill exercise test and cardiac magnetic resonance imaging (CMR) were performed according to initial screening results.ResultsThe mean age was 46.5 ± 18.6 years; 53.6% were men. All were classified with non-severe disease without overt cardiac manifestations and did not require intensive care. Median hospitalization stay was 17 days and median duration from discharge to screening was 11 days. Cardiac abnormalities were detected in 42.3% including sinus bradycardia (29.9%), newly detected T-wave abnormality (8.2%), elevated troponin level (6.2%), newly detected atrial fibrillation (1.0%), and newly detected left ventricular systolic dysfunction with elevated NT-proBNP level (1.0%). Significant sinus bradycardia with heart rate below 50 bpm was detected in 7.2% COVID-19 survivors, which appeared to be self-limiting and recovered over time. For COVID-19 survivors with persistent elevation of troponin level after discharge or newly detected T wave abnormality, echocardiography and CMR did not reveal any evidence of infarct, myocarditis, or left ventricular systolic dysfunction.ConclusionCardiac abnormality is common amongst COVID-survivors with mild disease, which is mostly self-limiting. Nonetheless, cardiac surveillance in form of ECG and/or serum biomarkers may be advisable to detect more severe cardiac involvement including atrial fibrillation and left ventricular dysfunction.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje